---
figid: PMC3861374__trd-75-188-g004
figlink: /pmc/articles/PMC3861374/figure/F4/
number: F4
caption: 'The mechanism of acquired resistance to epidermal growth factor receptor
  tyrosine kinase inhibitors (EGFR-TKIs). The secondary T790M mutation of EGFR leads
  to a decrease in the affinity to EGFR-TKIs. MET or insulin growth factor receptor
  (IGFR) activation induces the activation of phosphoinositide 3-kinase (PI3K)/Akt
  pathway independent of EGFR activation. HGF: hepatocyte growth factor; PTEN: phosphatase
  and tensin homolog; IGF: insulin growth factor. This figure is reprinted from the
  article by Nakata A and Gotoh N.'
pmcid: PMC3861374
papertitle: 'Molecular Basis of Drug Resistance: Epidermal Growth Factor Receptor
  Tyrosine Kinase Inhibitors and Anaplastic Lymphoma Kinase Inhibitors.'
reftext: Sei-Hoon Yang. Tuberc Respir Dis (Seoul). 2013 Nov;75(5):188-198.
pmc_ranked_result_index: '152248'
pathway_score: 0.9660011
filename: trd-75-188-g004.jpg
figtitle: Mechanism of acquired resistance to epidermal growth factor receptor tyrosine
  kinase inhibitors (EGFR-TKIs)
year: '2013'
organisms:
- Mus musculus
- Nicotiana tabacum
- Homo sapiens
ndex: e9dd6b4f-decf-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3861374__trd-75-188-g004.html
  '@type': Dataset
  description: 'The mechanism of acquired resistance to epidermal growth factor receptor
    tyrosine kinase inhibitors (EGFR-TKIs). The secondary T790M mutation of EGFR leads
    to a decrease in the affinity to EGFR-TKIs. MET or insulin growth factor receptor
    (IGFR) activation induces the activation of phosphoinositide 3-kinase (PI3K)/Akt
    pathway independent of EGFR activation. HGF: hepatocyte growth factor; PTEN: phosphatase
    and tensin homolog; IGF: insulin growth factor. This figure is reprinted from
    the article by Nakata A and Gotoh N.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT3
  - AKT2
  - MET
  - EGFR
  - AKT1
  - MAPKAP1
  - RICTOR
  - IGF1R
  - RAF1
  - MAP2K2
  - BRAF
  - HRAS
  - MAP2K1
  - ARAF
  - MTOR
  - MAPK1
  - KRAS
  - HGF
  - NRAS
  - RPTOR
  - MLST8
  - PTEN
  - SOS1
  - MAPK3
  - SHC3
  - ERBB3
  - SOS2
  - SHC2
  - SHC4
  - SHC1
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: MET
  symbol: MET
  source: hgnc_symbol
  hgnc_symbol: MET
  entrez: '4233'
- word: EGFR,
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MTORC1/2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MAPKAP1
  entrez: '79109'
- word: MTORC1/2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: RICTOR
  entrez: '253260'
- word: IGF1R
  symbol: IGF1R
  source: hgnc_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: MTORC1/2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: HGF
  symbol: HGF
  source: hgnc_symbol
  hgnc_symbol: HGF
  entrez: '3082'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: MTORC1/2
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: MTORC1/2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MLST8
  entrez: '64223'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC3
  entrez: '53358'
- word: HER3
  symbol: HER3
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB3
  entrez: '2065'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC2
  entrez: '25759'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC4
  entrez: '399694'
- word: MTORC1/2
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC1
  entrez: '6464'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC3861374__F4
redirect_from: /figures/PMC3861374__F4
figtype: Figure
---
